Preliminary evaluation of bleomycin in feline and canine squamous cell carcinoma.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000473:pathology / Q000662:veterinary*; D002371:Cat Diseases / Q000188:drug therapy* / Q000473:pathology; D002415:Cats; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D009062:Mouth Neoplasms / Q000188:drug therapy / Q000662:veterinary; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000662:veterinary*; D014067:Tonsillar Neoplasms / Q000188:drug therapy / Q000662:veterinary
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin